5085 Outer membrane efflux proteins (OEP)
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Mixed metal/non-metal compounds | 1 | 0.1 | 8.05× | not tested | |
| Lipids and lipid-like molecules | 4 | 0.7 | 6.07× | not tested | |
| Homogeneous non-metal compounds | 3 | 1.3 | 2.36× | not tested | |
| Homogeneous metal compounds | 3 | 2.9 | 1.03× | not tested | |
| Organic oxygen compounds | 1 | 1.2 | 0.85× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03796 | PLM | Palmitic Acid | 11 |
| DB03350 | NCO | Cobalt hexammine ion | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 17 |
| NAmetal | SODIUM ION | 12 |
| PLM | PALMITIC ACID | 11 |
| 3PK | (2S)-1-(pentanoyloxy)propan-2-yl hexanoate | 6 |
| NCO | COBALT HEXAMMINE(III) | 3 |
| XE | XENON | 3 |
| OYA | OCTANAL | 2 |
| HGmetal | MERCURY (II) ION | 1 |
| NImetal | NICKEL (II) ION | 1 |
| UNL | Unknown ligand | 1 |
| Z41 | (2S)-3-hydroxypropane-1,2-diyl dihexadecanoate | 1 |